within Pharmacolibrary.Drugs.N_NervousSystem.N01A_AnestheticsGeneral.N01AX07_Etomidate;

model Etomidate
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 1.82e-05,
    adminDuration = 600,
    adminMass = 20 / 1000000,
    adminCount = 1,
    Vd = 0.0022,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.00066,
    k12 = 1.1e-05,
    k21 = 1.1e-05);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Etomidate</td></tr><tr><td>ATC code:</td><td>N01AX07</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>20</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>2.2</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15.6</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Etomidate is a short-acting intravenous anesthetic agent used for the induction of general anesthesia and sedation for short procedures. It is known for its rapid onset and minimal cardiovascular effects, making it particularly useful in patients with hemodynamic instability. It is approved and clinically used for anesthesia induction.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult subjects after intravenous bolus administration.</p><h4>References</h4><ol><li><p>Lin, L, et al., &amp; Zhang, MZ (2012). Population pharmacokinetics of intravenous bolus etomidate in children over 6 months of age. <i>Paediatric anaesthesia</i> 22(4) 318–326. DOI:<a href=\"https://doi.org/10.1111/j.1460-9592.2011.03696.x\">10.1111/j.1460-9592.2011.03696.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21917057/\">https://pubmed.ncbi.nlm.nih.gov/21917057</a></p></li><li><p>Su, F, et al., &amp; Drover, DR (2015). Population pharmacokinetics of etomidate in neonates and infants with congenital heart disease. <i>Biopharmaceutics &amp; drug disposition</i> 36(2) 104–114. DOI:<a href=\"https://doi.org/10.1002/bdd.1924\">10.1002/bdd.1924</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25377074/\">https://pubmed.ncbi.nlm.nih.gov/25377074</a></p></li><li><p>Kaneda, K, et al., &amp; Han, TH (2011). Population pharmacokinetics and pharmacodynamics of brief etomidate infusion in healthy volunteers. <i>Journal of clinical pharmacology</i> 51(4) 482–491. DOI:<a href=\"https://doi.org/10.1177/0091270010369242\">10.1177/0091270010369242</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20498288/\">https://pubmed.ncbi.nlm.nih.gov/20498288</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N01AX07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Etomidate;
